Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Pathologic Complete Response × Radiation × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Esophageal Neoplasms 7 Uterine Cervical Neoplasms 6 Glioblastoma 6 Burkitt Lymphoma 6 Breast Neoplasms 6 Rhabdomyosarcoma 5 Carcinoma, Non-Small-Cell Lung 5 Esophageal Squamous Cell Carcinoma 4 Urinary Bladder Neoplasms 3 Sarcoma 3 Rectal Neoplasms 3 Medulloblastoma 3 Lung Neoplasms 3 Hodgkin Disease 3 Gliosarcoma 3 Brain Neoplasms 3 Vaginal Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Rhabdomyosarcoma, Embryonal 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Head and Neck Neoplasms 2 Endometrial Clear Cell Adenocarcinoma 2 Carcinoma, Squamous Cell 2

Interventions

Cyclophosphamide 3 Epirubicin 2 Docetaxel 2 Carboplatin 2 Capecitabine 2 Azacitidine 2 venetoclax 1 tegafur-gimeracil-oteracil 1 taxane 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pirarubicin 1 pertuzumab 1 pembrolizumab 1 olaparib 1 cc-486 1 Trastuzumab 1 Thalidomide 1 Radiotherapy 1 Radiation 1 Platinum 1 Paclitaxel 1 Oxaliplatin 1 Observation 1 Nivolumab 1 Monatide (IMS 3015) 1 Methotrexate 1 Magnetic Resonance Imaging 1 Leucovorin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡